REFERENCES
  1. International Team for the Revision of the International Criteria for Behçet’s Disease (ITR-ICBD). The International Criteria for Behçet’s Disease (ICBD): A collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014; 28(3):338-347. doi:10.1111/jdv.12107
  2. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013; 65(1):1-11. doi:10.1002/art.37715
  3. Watts RA, Hatemi G, Burns JC, Mohammad AJ. Global epidemiology of vasculitis. Nat Rev Rheumatol. 2022; 18(1):22-34. doi:10.1038/s41584-021-00718-8
  4. Alibaz-Oner F, Direskeneli H. Update on the diagnosis of Behçet’s disease. Diagnostics. 2023; 13(1):41. doi:10.3390/diagnostics13010041
  5. Wann TA, Bah MLY, Baldé MS, Baldé AK, Camara T, Barro IKS, et al. Epidemiology and clinical profile of Behcet’s disease in a Sub-Saharan country: About five observations. Open J Intern Med. 2023; 13(2):120-125. doi:10.4236/ojim.2023.132013
  6. Giannessi C, Smorchkova O, Cozzi D, Zantonelli G, Bertelli E, Moroni C, et al. Behçet’s disease: A radiological review of vascular and parenchymal pulmonary involvement. Diagnostics (Basel). 2022; 12(11):2868. doi:10.3390/diagnostics12112868
  7. Tascilar K, Melikoglu M, Ugurlu S, Sut N, Caglar E, Yazici H. Vascular involvement in Behçet’s syndrome: A retrospective analysis of associations and the time course. Rheumatology (Oxford). 2014; 53(11):2018-2022. doi:10.1093/rheumatology/keu233
  8. Merashli M, Eid RE, Uthman I. A review of current management of vasculo-Behcet’s. Curr Opin Rheumatol. 2018; 30(1):50-56. doi:10.1097/BOR.0000000000000458
  9. Behcet H. Uber rezidiverende, aphthose, durch ein virus verursachte gescgwure am mund, am auge und an den genitalen. Dermatol Wochenschr. 1937; 105:1152-1157.
  10. Kone-Paut I, Barete S, Bodaghi B, Deiva K, Desbois AC, Galeotti C, et al. French recommendations for the management of Behçet’s disease. Orphanet J Rare Dis. 2021; 16(Suppl 1):352. doi:10.1186/s13023-020-01620-4
  11. Shadmanfar S, Masoumi M, Davatchi F, Akhlaghi M, Faezi ST, Kavosi H, et al. Cardiac manifestations in Iranian patients with Behçet’s disease. J Tehran Heart Cent. 2021; 16(3):109-112. doi:10.18502/jthc.v16i3.8187
  12. Demirelli S, Degirmenci H, Inci S, Arisoy A. Cardiac manifestations in Behcet’s disease. Intractable Rare Dis Res. 2015; 4(2):70-75. doi:10.5582/irdr.2015.01007
  13. Desbois AC, Wechsler B, Cluzel P, Helft G, Boutin D, Piette JC, et al. Cardiovascular involvement in Behçet’s disease. Rev Med Interne. 2014; 35(2):103-111. doi:10.1016/j.revmed.2013.12.002
  14. Kakehi E, Adachi S, Fukuyasu Y, Hashimoto Y, Yoshida M, Osaka T, et al. Superior mesenteric artery vasculitis in Behçet’s disease: A case report and literature review. Intern Med. 2019; 58(1):127-133. doi:10.2169/internalmedicine.1290-18
  15. Makhzoum JP, Grayson PC, Ponte C, Robson J, Suppiah R, Watts RA, et al. Pulmonary involvement in primary systemic vasculitides. Rheumatology (Oxford). 2022; 61(1):319-330. doi:10.1093/rheumatology/keab325
  16. Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, et al. 2018 update of the EULAR recommendations for the management of Behçet’s syndrome. Ann Rheum Dis. 2018; 77(6):808-818. doi:10.1136/annrheumdis